Leap Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 49.9%.

Top 25 shareholders own 57.1% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
13.9%	Gilead Sciences, Inc.	5,319,148	€15.0m	0%	no data
8.05%	Balyasny Asset Management L.P.	3,085,104	€8.7m	-0.48%	0.02%
6.37%	Samsara BioCapital LLC	2,442,352	€6.9m	0%	0.86%
3.6%	683 Capital Management, LLC	1,380,500	€3.9m	6.19%	0.35%
3.31%	Rock Springs Capital Management LP	1,266,546	€3.6m	0%	0.11%
3.17%	BeiGene, Ltd.	1,215,306	€3.4m	65.4%	no data
3.06%	Baker Bros. Advisors LP	1,172,175	€3.3m	0%	0.03%
2.76%	Simplify Asset Management Inc.	1,056,895	€3.0m	67.4%	0.18%
2.69%	The Vanguard Group, Inc.	1,029,153	€2.9m	3.3%	no data
1.85%	Laurion Capital Management LP	709,219	€2.0m	0%	0.12%
1.77%	HealthCare Ventures LLC	676,320	€1.9m	0%	100.0%
1.21%	Citadel Advisors LLC	463,448	€1.3m	-49.5%	no data
0.86%	Geode Capital Management, LLC	329,291	€927.3k	18%	no data
0.84%	Key Client Fiduciary Advisors, LLC	321,923	€906.6k	13%	0.37%
0.68%	James Cavanaugh	262,053	€738.0k	0%	no data
0.53%	BlackRock, Inc.	202,963	€571.6k	18%	no data
0.48%	Acadian Asset Management LLC	183,663	€517.2k	-28.4%	no data
0.43%	UBS O'Connor LLC	165,108	€465.0k	10.2%	0.04%
0.31%	Acuta Capital Partners, LLC	120,500	€339.3k	-38.2%	0.26%
0.27%	Exome Asset Management LLC	102,631	€289.0k	0%	0.18%
0.21%	Dimensional Fund Advisors LP	81,463	€229.4k	27.3%	no data
0.21%	HANSAINVEST Hanseatische Investment-GmbH	81,000	€228.1k	0%	0.01%
0.19%	Douglas Onsi	73,646	€207.4k	0%	no data
0.19%	State Street Global Advisors, Inc.	71,813	€202.2k	0%	no data
0.17%	Susquehanna International Group, LLP, Asset Management Arm	66,246	€186.6k	453%	no data